246 related articles for article (PubMed ID: 7527506)
1. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
Ogawa T; Yorioka N; Yamakido M
Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
[TBL] [Abstract][Full Text] [Related]
2. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
Takahashi T; Inaba S; Okada T
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
[TBL] [Abstract][Full Text] [Related]
5. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
[TBL] [Abstract][Full Text] [Related]
6. C5b-9 and adhesion molecules in human idiopathic membranous nephropathy.
Papagianni AA; Alexopoulos E; Leontsini M; Papadimitriou M
Nephrol Dial Transplant; 2002 Jan; 17(1):57-63. PubMed ID: 11773463
[TBL] [Abstract][Full Text] [Related]
7. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy.
Schulze M; Donadio JV; Pruchno CJ; Baker PJ; Johnson RJ; Stahl RA; Watkins S; Martin DC; Wurzner R; Gotze O
Kidney Int; 1991 Sep; 40(3):533-8. PubMed ID: 1787650
[TBL] [Abstract][Full Text] [Related]
8. Cellular response to injury in membranous nephropathy.
Nangaku M; Shankland SJ; Couser WG
J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
[TBL] [Abstract][Full Text] [Related]
10. Immunoelectron microscopic localization of membrane attack complex and hepatitis B e antigen in membranous nephropathy.
Akano N; Yoshioka K; Aya N; Miyamoto H; Takemura T; Tohda M; Maki S
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):325-30. PubMed ID: 2496520
[TBL] [Abstract][Full Text] [Related]
11. Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions.
Sobel RA; Chen M; Maeda A; Hinojoza JR
J Neuropathol Exp Neurol; 1995 Mar; 54(2):202-13. PubMed ID: 7533209
[TBL] [Abstract][Full Text] [Related]
12. Abnormal distribution of mesangium-specific laminin in glomeruli of patients with idiopathic membranous nephropathy.
Horikoshi S; Ebihara I; Nakamura T; Koide H
Nephron; 1999; 81(3):284-8. PubMed ID: 10050082
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of membranous nephropathy.
Couser WG; Abrass CK
Annu Rev Med; 1988; 39():517-30. PubMed ID: 2967047
[TBL] [Abstract][Full Text] [Related]
15. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Hanamura K; Tojo A; Kinugasa S; Asaba K; Onozato ML; Uozaki H; Fukayama M; Fujita T
Hum Pathol; 2011 May; 42(5):649-58. PubMed ID: 21292302
[TBL] [Abstract][Full Text] [Related]
16. Distribution of extracellular matrix receptors in various forms of glomerulonephritis.
Shikata K; Makino H; Morioka S; Kashitani T; Hirata K; Ota Z; Wada J; Kanwar YS
Am J Kidney Dis; 1995 May; 25(5):680-8. PubMed ID: 7538261
[TBL] [Abstract][Full Text] [Related]
17. Complement activation products in the circulation and urine of primary membranous nephropathy.
Zhang MF; Huang J; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Cui Z; Liu G; Zhao MH
BMC Nephrol; 2019 Aug; 20(1):313. PubMed ID: 31399080
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-morphologic heterogeneity of minimal changes in glomerulonephritis].
Shestakova LA; Varshavskiĭ VA
Arkh Patol; 1994; 56(6):22-8. PubMed ID: 7605213
[TBL] [Abstract][Full Text] [Related]
19. C5b-9 deposition in children with glomerular diseases.
Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy.
Neale TJ; Rüger BM; Macaulay H; Dunbar PR; Hasan Q; Bourke A; Murray-McIntosh RP; Kitching AR
Am J Pathol; 1995 Jun; 146(6):1444-54. PubMed ID: 7778683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
